ALKS
ALKS
NASDAQ · Biotechnology

Alkermes Plc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$28.40
+0.69 (+2.49%)
As of Mar 24, 9:52 PM ET ·
Analyst Consensus
Strong Buy
24
Analysts
High
Coverage
Buy 20 83%
Hold 4 17%
Sell 0 0%
Price Target
Analyst Price Target +345.1% upside
Low Target $90.34
Average Target $126.40
High Target $146.79
Current Price $28.40
Current
$28.40
Target
$126.40
$90.34 $126.40 avg $146.79
Scenario Analysis
Bear Case
$90.34
218.1%
Low target
Base Case
$126.40
+345.1%
Avg target
Bull Case
$146.79
+416.9%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$36.32
-21.8% from high
52-Week Low
$25.17
+12.9% from low
50-Day SMA
$31.02
-8.4% vs SMA
200-Day SMA
$29.87
-4.9% vs SMA
RSI (14)
32.3
Neutral
Target vs 52W High
$126.40
+248.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +25.5%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -45.2%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.6%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -2.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -66.8%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 +3.1%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -26.5%